SAT-282 Outcomes in Children Treated with Growth Hormone for Prader-Willi Syndrome: Data from the Answer® Program and Nordinet® International Outcome Study (IOS)

por Angulo, Moris, Abuzzahab, Mary, Pietropoli, Alberto, Ostrow, Vlady, Tauber, Maithe
Publicado 2019

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency

por Maniatis, Aristides K, Nadgir, Ulhas, Saenger, Paul, Mick, Gail, Reifschneider, Kent L, Abuzzahab, Mary Jennifer, Deeb, Larry, Fox, Larry A, Woods, Katie A, Peng, Jessica M, Karpf, David B, Shu, Aimee D, Song, Wenjie, Casella, Samuel J, Thornton, Paul S
Publicado 2020